Skip to content

Effect of Artronat on the Quality of Life of Patient With Osteoarthritis

Effet du complément Alimentaire ARTRONAT(R) Sur la réduction de la Gonalgie Chez Des Sujets Arthrosiques

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01356199
Enrollment
7
Registered
2011-05-19
Start date
2011-10-31
Completion date
2013-12-31
Last updated
2014-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

Gonalgia, Quality of Life, Dietary supplement, Nutrition

Brief summary

The purpose of this study is to determine whether the nutritional supplement ARTRONAT improves the quality of life of patients with osteoarthritis.

Detailed description

Osteoarthritis is a degenerative disease that greatly impairs the quality of life of patients. A nutritional supplement may help, in association with the normal treatment of osteoarthritis, improving the quality of life of such patients, in reducing pain and/or improving join flexibility.

Interventions

DIETARY_SUPPLEMENTARTRONAT

Dietary supplement containing Glucosamine, Chondroïtine and manganese. 6 per day for 8 months.

DIETARY_SUPPLEMENTPLACEBO

PLACEBO. 6 per day for 8 months.

Sponsors

RDVC Produit de Santé.
CollaboratorUNKNOWN
Association Nationale de Prévention Médicale.
CollaboratorUNKNOWN
Lescuyer Laboratory
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* age 40-75 years * BMI 18.5-30 * osteoarthritis type II or III

Exclusion criteria

* osteoarthritis type I or IV * allergy to one of the component of the supplement * blood pressure \> 14/8 * history of knee surgery

Design outcomes

Primary

MeasureTime frameDescription
Reduction of gonalgiaT8 monthsmeasure with the WOMAC.

Secondary

MeasureTime frameDescription
Evaluation of the satisfactory relief of symptoms of osteoarthritis at each visit after the beginning of supplementation, assessed by the patients.T2, T4, T6, T8 monthsSubjective global assessment measured on a 10-cm graduated scale (Visual Analogue Scale)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026